CMC Biologics AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CMC Biologics AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5141
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CMC Biologics A/S (CMC Biologics), formerly CMC Biopharmaceuticals A/S, a subsidiary of Asahi Glass Co., Ltd., is a contract process development and manufacturer of biopharmaceuticals. The company’s service portfolio encompasses process development, cGMP manufacturing, and quality and regulatory services. Its process development services include cell culture development, upstream and downstream process development, analytical formulation stability for monoclonal antibodies. CMC Biologics’ cGMP manufacturing services include mammalian cell culture and microbial fermentation. It also offers a proprietary Chinese hamster ovary cell line development platform called CHEF1, which delivers cell lines in rapid time frames. The company has manufacturing facilities in Berkeley, California and Seattle, Washington. CMC Biologics is headquartered in Copenhagen, Denmark.

CMC Biologics AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMC Biologics A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
CMC Biologics Acquires Manufacturing Operations And Affiliated Assets From Xoma 10
Partnerships 11
CMC ICOS Biologics Enters into Co-development Agreement with Harpoon Therapeutics 11
Catalyst Biosciences Enters into Development and Manufacturing Services Agreement with CMC ICOS Biologics 12
CMC Biologics and IDT Biologika Enter into Agreement 13
CMC Biologics Enters into Agreement with Immunocore 14
CMC Biologics Enters into Agreement with Path Malaria Vaccine Initiative 15
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 16
CMC Biologics Enters into Co-Development Agreement with OncoSynergy for OS-2966 17
CMC Biologics Enters Into Agreement With OncoSynergy For OS2966 Drug Program 18
CMC Biologics Enters Into Co-Development Agreement With RuiYi For RYI-008 Cell Line 19
Acquisition 20
Asahi Glass Acquires CMC Biologics for USD508.6 Million 20
CMC Biologics A/S – Key Competitors 22
CMC Biologics A/S – Key Employees 23
CMC Biologics A/S – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Jan 08, 2018: AGC Bioscience, Biomeva, and CMC Biologics to provide services under the brand AGC Biologics 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
CMC Biologics A/S, Pharmaceuticals & Healthcare, Key Facts 2
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMC Biologics A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMC Biologics A/S, Deals By Therapy Area, 2012 to YTD 2018 8
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CMC Biologics Acquires Manufacturing Operations And Affiliated Assets From Xoma 10
CMC ICOS Biologics Enters into Co-development Agreement with Harpoon Therapeutics 11
Catalyst Biosciences Enters into Development and Manufacturing Services Agreement with CMC ICOS Biologics 12
CMC Biologics and IDT Biologika Enter into Agreement 13
CMC Biologics Enters into Agreement with Immunocore 14
CMC Biologics Enters into Agreement with Path Malaria Vaccine Initiative 15
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 16
CMC Biologics Enters into Co-Development Agreement with OncoSynergy for OS-2966 17
CMC Biologics Enters Into Agreement With OncoSynergy For OS2966 Drug Program 18
CMC Biologics Enters Into Co-Development Agreement With RuiYi For RYI-008 Cell Line 19
Asahi Glass Acquires CMC Biologics for USD508.6 Million 20
CMC Biologics A/S, Key Competitors 22
CMC Biologics A/S, Key Employees 23
CMC Biologics A/S, Other Locations 24
CMC Biologics A/S, Subsidiaries 24

List of Figures
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMC Biologics A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CMC Biologics AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acuity Brands, Inc.:戦略・SWOT・企業財務分析
    Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Landis+Gyr AG (LAND):電力:M&Aディール及び事業提携情報
    Summary Landis+Gyr AG (Landis+Gyr) is an integrated energy management company that provide end-to-end advanced metering solutions. It delivers comprehensive services including cloud services, managed services, smart grid services, software services, solutions consulting and support services. The com …
  • Globus Spirits Limited:企業の戦略・SWOT・財務情報
    Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report Summary Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MolecularMD Corp:医療機器:M&Aディール及び事業提携情報
    Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging s …
  • Ontario Teachers’ Pension Plan:企業のM&A・事業提携・投資動向
    Ontario Teachers' Pension Plan - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ontario Teachers' Pension Plan Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Century Casinos Inc:戦略・SWOT・企業財務分析
    Century Casinos Inc - Strategy, SWOT and Corporate Finance Report Summary Century Casinos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Windtree Therapeutics Inc (WINT)-医療機器分野:企業M&A・提携分析
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Align Technology Inc (ALGN):企業の財務・戦略的SWOT分析
    Align Technology Inc (ALGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Guangzhou Institute of Biomedicine and Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that develops protocols for disease control and prevention. The institute conducts research in the areas of stem cell and regenerative medicine, chemical biology, immunology and infectious diseases, public health, a …
  • Celtic Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celtic Healthcare Inc (Celtic), a subsidiary of Graham Holdings Company is a healthcare service provider that offers homecare, hospice, and virtual care services. The center’s hospice services include 24-hour on-call nursing services; physical, emotional, and spiritual assessment, care, supp …
  • Manali Petrochemicals Ltd (MANALIPETC):企業の財務・戦略的SWOT分析
    Summary Manali Petrochemicals Ltd (MPL), a subsidiary of Southern Petrochemical Industries Corp Ltd, is a chemical company that develops and markets petrochemical products. The company offers products such as propylene oxide, propylene glycol, flexible and molded polyols, rigid polyols and elastomer …
  • Apex Biotechnology Corp (1733)-医療機器分野:企業M&A・提携分析
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Deloitte Touche Tohmatsu Limited:企業の戦略・SWOT・財務分析
    Deloitte Touche Tohmatsu Limited - Strategy, SWOT and Corporate Finance Report Summary Deloitte Touche Tohmatsu Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • HeartWare International Inc:製品パイプライン分析
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that co …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • BFS Group Ltd:企業の戦略・SWOT・財務分析
    BFS Group Ltd - Strategy, SWOT and Corporate Finance Report Summary BFS Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fountain Biopharma Inc (4159):製薬・医療:M&Aディール及び事業提携情報
    Summary Fountain Biopharma Inc (Fountain Biopharma), a subsidiary of Microbio Co Ltd, is a developer of therapeutic monoclonal antibodies and DNA aptamers. The company’s technologies include IgE development platform, IEA’s drug development platform and tumor stem cell culture platform. Its IgE devel …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆